Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-12

Clinical Trial Update: Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effectiveness of N-acetyl cysteine, acetyl L-carnitine, and medicated paraffin oil in aluminium phosphide poisoning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetyl-L-carnitine (N-acetyl-L-carnitine)
  • Medicated paraffin oil (medicated paraffin oil)
  • N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Cairo University | Conditions: the Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ Damage | Phase 4 | Status: UNKNOWN